Physician profile
Frank Colarusso
NPI 1558314047
$819.07
in general payments reported to CMS, 2019-2025
19 companies · $151 in 2025
The $151 reported for 2025 was more than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $59.44 · 2021: $25.85 · 2022: $103 · 2023: $93.78 · 2024: $119 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $120.95 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $104.15 | 2019-2023 | Euflexxa |
| Globus Medical, INC. | $98.61 | 2025 | Senza |
| Nuvasive, INC. | $88.09 | 2019-2020 | |
| Bioventus LLC | $62.19 | 2022-2024 | Durolane |
| Pacira Therapeutics, INC. | $42.53 | 2019 | |
| Abbott Laboratories | $35.96 | 2024-2025 | Eterna, Proclaim |
| Zimmer Biomet Holdings, INC. | $34.63 | 2022 | |
| Nalu Medical, INC. | $33.10 | 2025 | Nalu Neurostimulation System |
| Heraeus Medical, LLC. | $27.76 | 2023 | Palacos |
| Nevro Corp. | $25.80 | 2023 | Senza |
| Stryker Corporation | $23.04 | 2019 | |
| Smith+Nephew, INC. | $22.87 | 2024 | Pico 14 |
| Boston Scientific Corporation | $22.13 | 2024 | |
| Si-Bone, INC. | $17.74 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $17.60 | 2024 | Rs 4i Plus Sequential Stimulator |
| Horizon Therapeutics Plc | $14.88 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.31 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.73 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Colarusso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.